WIELISA ANTI-GBM TEST SYSTEM— 510(k) K974169
Substantially EquivalentWieslab AB
FDA 510(k) clearance K974169 for WIELISA ANTI-GBM TEST SYSTEM, Substantially Equivalent on 1998-02-17. Applicant: Wieslab AB. Device class: 2.
Clearance details
- Applicant
- Wieslab AB
- Product code
- Code DBL
- Device class
- Class 2
- Regulation
- 21 CFR 866.5660
- Advisory panel
- Immunology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Frederick, MD, US
Recent devices under product code DBL
view allMore clearances from Wieslab AB
view allData sourced from openFDA. This site is unofficial and independent of the FDA.